BioSpace News Archive

Fact.MR – A Market Research and Competitive Intelligence Provider: According to OECD, Global spending on pharmaceuticals was US$ 1,120.6 Bn in 2015 and is expected to increase at a CAGR of 7.1% during 2016 - 2030.

Kodiak Sciences Inc. announced that its BEACON Phase 3 study of tarcocimab tedromer, its novel antibody biopolymer conjugate, met the primary endpoint of non-inferior change from baseline in visual acuity at week 24 compared to aflibercept in patients with macular edema due to retinal vein occlusion.

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, announced positive topline results from its Phase 3 EMERGENT-2 trial evaluating the efficacy, safety, and tolerability of its lead investigational therapy, KarXT, in adults with schizophrenia.

Pfizer Inc. and Global Blood Therapeutics, Inc. announced the companies have entered into a definitive agreement under which Pfizer will acquire GBT, a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities, starting with sickle cell disease.

Eli Lilly and Company announced the availability of a new, citrate-free formulation of Taltz® injection 80 mg/mL.

Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced financial results for the second quarter of 2022 and provided an update on the Company’s business operations and clinical development programs.

TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced that it will report its second quarter 2022 financial results on Monday, August 15, 2022, at 8:30 a.m. ET prior the opening of the U.S. financial markets.

ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results; Reports Record Net Revenues and Raises Full-Year 2022 Net Revenue Guidance for Purified Cortrophin ® Gel.

Wilmington, Delaware, United States, Transparency Market Research Inc. – As per the latest research report on global hemostasis tissue sealing agents market by the Transparency Market Research, the industry is poised to expand at a stable growth rate of 8.3 % over the forecast period of 2019 to 2027.

Wilmington, Delaware, United States, Transparency Market Research Inc. – Viscosupplement drugs can be administered using single injection, three injections, and five injections.